New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins

Kyuho Kim^{1

2}, Henry N Ginsberg³, Sung Hee Choi^{1

4}

Affiliations

¹ Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
² Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
³ Department of Preventive Medicine and Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
⁴ Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Published Erratum

Kyuho Kim et al. Diabetes Metab J. 2022 Sep.

. 2022 Sep;46(5):817-818.

doi: 10.4093/dmj.2022.0295. Epub 2022 Sep 19.

Kyuho Kim^{1

2}, Henry N Ginsberg³, Sung Hee Choi^{1

4}

¹ Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
² Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
³ Department of Preventive Medicine and Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
⁴ Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

No abstract available

Erratum for

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins.
Kim K, Ginsberg HN, Choi SH. Kim K, et al. Diabetes Metab J. 2022 Jul;46(4):517-532. doi: 10.4093/dmj.2022.0198. Epub 2022 Jul 27. Diabetes Metab J. 2022. PMID: 35929170 Free PMC article. Review.